Screening methods for compounds useful for treating pancreatic dysfunction
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 9, 2015
Grant Date -
Nov 10, 2011
app pub date -
Feb 18, 2011
filing date -
May 29, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully